Centessa Pharmaceuticals plc - ADR

NASDAQ:CNTA   11:29:24 AM EDT
17.90
-0.13 (-0.72%)
Earnings Announcements

Centessa Q2 Loss Per Share $0.65

Published: 08/16/2021 11:24 GMT
Centessa Pharmaceuticals plc - ADR (CNTA) - Q2 Loss per Share $0.65.
Centessa- Expects Cash, Equivalents As of June 30, to Fund Its Operations Until End of 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.55

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.63

More details on our Analysts Page.